Cargando…
Atypical Neuroleptic Malignant Syndrome in the Intensive Care Unit: A Case Report
AIMS: Neuroleptic malignant syndrome (NMS) is a rare condition experienced by patients taking typical and/or atypical antipsychotic medications. There are well-established diagnostic criteria for NMS. However, differentiating it from serotonin syndrome and malignant hyperthermia—particularly in the...
Autor principal: | Grant, Heidi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10345758/ http://dx.doi.org/10.1192/bjo.2023.345 |
Ejemplares similares
-
Atypical Neuroleptic Malignant Syndrome in a COVID-19 Intensive Care Unit
por: Durbach, Joshua R, et al.
Publicado: (2022) -
Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006) -
Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine
por: Leonardo, Quevedo-Florez, et al.
Publicado: (2017) -
An Unusual Case of Neuroleptic Malignant Syndrome on a Stable Dose of Antipsychotic
por: Sanger, Emily, et al.
Publicado: (2023) -
CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002)